TrialClinical cardiology2018

Consistent LDL-C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies.

Erik Stroes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.